Journal article icon

Journal article

A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics

Abstract:

Introduction: Developing and evaluating novel compounds for treatment or prophylaxis of emerging infectious diseases is costly and time-consuming. Repurposing of already available marketed compounds is an appealing option as they already have an established safety profile. This approach could substantially reduce cost and time required to make effective treatments available to fight the COVID-19 pandemic. However, this approach is challenging since many drug candidate...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1080/17512433.2022.2113388

Authors


More by this author
Role:
Author
ORCID:
0000-0002-7570-4665
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0003-3839-9777
More by this author
Role:
Author
ORCID:
0000-0003-4242-9289
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0002-5322-912X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0003-4566-4030
Publisher:
Taylor and Francis
Journal:
Expert Review of Clinical Pharmacology More from this journal
Volume:
15
Issue:
8
Pages:
945-958
Publication date:
2022-08-26
Acceptance date:
2022-08-09
DOI:
EISSN:
1751-2441
ISSN:
1751-2433
Pmid:
36017624
Language:
English
Keywords:
Pubs id:
1276402
Local pid:
pubs:1276402
Deposit date:
2023-01-09

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP